Abbott Laboratories
Search results
employees turning possibilities into reality for people and patients. Our products are approved in individual countries for specific uses and the information provided is governed by local regulations. Product availability, name and indicated use may vary by country. Please contact your local AbbVie office to learn more about products available ...
- Pipeline
Target GLP-2 agonist. Type of molecule Biologic. CLF065 is a...
- Pipeline
AbbVie | Pharmaceutical Research & Development. Inventing the Future of Medicine. By investing in groundbreaking technologies, we’re on a mission to deliver better solutions to patients. Learn more. Pipeline. Advancing medicines with strong clinical performance in areas of great need. Focus Areas.
At AbbVie, we combine advanced science, expertise and passion to solve serious health issues and have a remarkable impact on people’s lives. We are committed to improving health care in markets where we operate. Passionate about our work. Responsible for our actions.
AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. It is ranked sixth on the list of largest biomedical companies by revenue. In 2023, the company's seat in Forbes Global 2000 was 74. [2] .
May 7, 2024 · AbbVie pharmaceuticals combines advanced science with expertise to make strides in drug and treatment discovery, making a remarkable impact on people's lives.
Our Products. A Portfolio of Medicines. We aim to develop innovative therapies for health conditions where there is significant need. Our medicines are approved in individual countries for different uses around the globe. Explore.
Target GLP-2 agonist. Type of molecule Biologic. CLF065 is a long-acting GLP2R agonist being evaluated for inflammatory bowel disease. CLF065 developed by Calibr, a division of Scripps Research, in a first-in-patient trial; AbbVie holds option for additional development.
